AgingResearch.News
Cancers

Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver Disease

By Amit G. Singal, Mark Camardo, Janelle J. Bruinsma, Show 2 more authorsBinu V. John
Figure 1. ROC Curves for mt-HBT, GALAD, and AFP in Detecting Early-Stage HCC versus Controls.
Open the figure at full size
Figure 1. ROC Curves for mt-HBT, GALAD, and AFP in Detecting Early-Stage HCC versus Controls.ROC Curves for mt-HBT, GALAD, and AFP in Detecting Early-Stage HCC versus Controls.Singal et al.
Case-control study of 649 peopleBiomarkers

Multicentre, declared ties to: Genentech, AstraZeneca, Eisai and 27 more

Paper

The paper

Amit G. Singal, Mark Camardo, Janelle J. Bruinsma, Show 2 more authorsBinu V. John

The University of Texas Southwestern Medical Center; University of Miami

Cancers, 27 Aug 2026

doi.org/10.3390/cancers18172777PubMed 42738299

More on DNA methylation